OGEN
Price:
$0.6224
Market Cap:
$2.81M
Oragenics, Inc. (OGEN) is a U.S.-based biotechnology firm primarily focused on creating treatments for infectious diseases. Among its pipeline assets are two vaccine candidates designed to combat the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2): NT-CoV2-1, an intranasal formulation, and Terra CoV-2, an intramuscular option. Beyond its infectious disease focus, Oragenics also has other experimental treatments under development, including LPT3-04, targeting weight loss, and SMaRT Replacement Therapy, a topical solution aimed at preventing dental cavities. Strategic alliances are also a part of its operations. This includes a licensing deal with Noachis Terra Inc. for patent...[Read more]
Industry
Biotechnology
IPO Date
2004-02-25
Stock Exchange
AMEX
Ticker
OGEN
According to Oragenics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -3242702.00. This represents a change of -9.94% compared to the average of -3600788.51 of the last 4 quarters.
The mean historical Enterprise Value of Oragenics, Inc. over the last ten years is 506.72M. The current -3242702.00 Enterprise Value has changed -163.99% with respect to the historical average. Over the past ten years (40 quarters), OGEN's Enterprise Value was at its highest in in the March 2021 quarter at 2.77B. The Enterprise Value was at its lowest in in the September 2025 quarter at -10988482.21.
Average
506.72M
Median
373.06M
Minimum
-2482956.08
Maximum
1.48B
Discovering the peaks and valleys of Oragenics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 104.57%
Maximum Annual Enterprise Value = 1.48B
Minimum Annual Increase = -103.41%
Minimum Annual Enterprise Value = -2482956.08
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | -2482956.08 | -103.41% |
| 2024 | 72.84M | -80.67% |
| 2023 | 376.86M | 2.06% |
| 2022 | 369.26M | -75.12% |
| 2021 | 1.48B | 99.32% |
| 2020 | 744.73M | 15.26% |
| 2019 | 646.15M | 104.57% |
| 2018 | 315.85M | -7.39% |
| 2017 | 341.07M | -52.53% |
| 2016 | 718.50M | -56.31% |
The current Enterprise Value of Oragenics, Inc. (OGEN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
149.07M
5-year avg
460.17M
10-year avg
506.72M
Oragenics, Inc.’s Enterprise Value is less than AIM ImmunoTech Inc. (139.50K), less than KALA BIO, Inc. (55.91M), less than Ensysce Biosciences, Inc. (1.83M), less than Soligenix, Inc. (-1266892.00), less than Qualigen Therapeutics, Inc. (971.81K), less than Can-Fite BioPharma Ltd. (7.39B), less than Xenetic Biosciences, Inc. (-1303306.00), less than CNS Pharmaceuticals, Inc. (91.17K), greater than Kazia Therapeutics Limited (-36620371.31), greater than Titan Pharmaceuticals, Inc. (-66329351.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 139.50K | $1.38M | |
| 55.91M | $57.68M | |
| 1.83M | $2.33M | |
| -1266892.00 | $4.43M | |
| 971.81K | $5.43M | |
| 7.39B | $1.53M | |
| -1303306.00 | $6.04M | |
| 91.17K | $2.81M | |
| -36620371.31 | $23.13M | |
| -66329351.00 | $3.11M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oragenics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Oragenics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Oragenics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Oragenics, Inc. (OGEN)?
What is the 3-year average Enterprise Value for Oragenics, Inc. (OGEN)?
What is the 5-year average Enterprise Value for Oragenics, Inc. (OGEN)?
How does the current Enterprise Value for Oragenics, Inc. (OGEN) compare to its historical average?